Hypertension remains the leading modifiable driver of cardiovascular disease and premature death.1 Even with multiple drug classes available, nearly 70% of adults have uncontrolled blood pressure.2 ...
Oct. 14, 2025 — Nurea has announced that its PRAEVAorta 2 software has received FDA 510(k) clearance, enabling entry ...
Oct. 13, 2025 — Medtronic plc recently announced it has received U.S. Food and Drug Administration (FDA) labeling ...
Oct. 10, 2025 — Johnson & Johnson MedTech, in collaboration with the Heart Rhythm Clinical and Research Solutions, LLC ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Oct. 10, 2025 — Berlin Heals Holding AG, a clinical-stage medical device company focused on revolutionizing the care of ...
Septe. 30, 2025 -- GE HealthCare Vivid iq Ultrasound system has been selected by NASA for delivery to the International ...
Oct. 8, 2025 — Viz.ai recently launched Viz ACS, a new solution in the Viz Cardio Suite. Designed to unite the acute ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Oct. 7, 2025 — RSNA Ventures, a mission-aligned subsidiary of Radiological Society of North America (RSNA), has ...
Oct. 7, 2025 — Cagent Vascular has announced the commercial launch of the Serranator PTA Serration Balloon Catheter in 7 ...
Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Oct. 7, 2025 — Nobles Medical Technology II, a provider of cardiovascular closure solutions, has announced that the U.S ...
Oct. 2, 2025 — AorticLab recently announced the U.S. Food and Drug Administration (FDA) has approved its Investigational ...
Sept. 26, 2025 — A new guideline from the American Society of Echocardiography (ASE) offers updated and expanded ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Oct. 1, 2025 – Intelerad has announced the next generation of InteleHeart, a reimagined, all-in-one cardiology platform ...

Hypertension remains the leading modifiable driver of cardiovascular disease and premature death.1 Even with multiple ...
Sept. 30, 2025 — Biograph and Caristo Diagnostics have announced a partnership for Biograph to become the first U.S ...